Thermo Fisher Scientific Inc.
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$682.65−14.35 (-2.06%)
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Microbiology by Year
Microbiology (Clinical Microbiology & Culture Media) ($M)
Thermo Fisher Scientific Microbiology: $645M in FY2025, up 1.9% from a year earlier.
Latest, FY2025
645
Period ended Dec 31, 2025
Change on a year earlier
+1.9%
633 in FY2024
History
3 years
Since FY2023
Sources
1
SEC Form 10-K (10k_2025, filed 2026-02-26)
Where the FY2025 figure comes from
“|| Microbiology | 645 | 633 | 618”
Source: SEC Form 10-K (10k_2025, filed 2026-02-26) ↗
Reported in SEC 10-K / 10-Q Note 6 (Revenue by Business).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Microbiology (Clinical Microbiology & Culture Media) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 645 | +1.9% | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 633 | +2.4% | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 618 | – | SEC Form 10-K (10k_2025, filed 2026-02-26) ↗ |
Cite this data
StockData. (2026). Thermo Fisher Scientific Microbiology ($M), annual FY2023–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/rev-biz-microbiology
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.